Search

Your search keyword '"Westervelt, Peter"' showing total 995 results

Search Constraints

Start Over You searched for: Author "Westervelt, Peter" Remove constraint Author: "Westervelt, Peter" Search Limiters Full Text Remove constraint Search Limiters: Full Text
995 results on '"Westervelt, Peter"'

Search Results

2. Genomic landscape of TP53-mutated myeloid malignancies

3. SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

4. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes

5. The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

6. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

9. An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes

10. Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

13. First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

14. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

15. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

16. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

17. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

18. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

19. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

20. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

21. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

22. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

23. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

24. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

25. Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma

27. Abstract 4342: Predictive precision medicine platform accurately predicts individual patient response to AML treatments to maximize outcomes

30. Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

37. Mgta-117, an Anti-CD117-Amanitin Antibody-Drug Conjugate, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics, and Pharmacodynamics Initial Findings from a Phase 1/2 Study

39. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

42. Phase I Study of Baricitinib Gvhd Prophylaxis in HLA-Matched, Peripheral Blood Allogeneic Hematopoietic Cell Transplant

43. Mgta-117, an Anti-CD117 Antibody-Drug Conjugated with Amanitin, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics and Pharmacodynamics Initial Findings from a Phase 1/2 Study

45. Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802

46. Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen

47. Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression

49. Role of TP53 mutations in the origin and evolution of therapy--related acute myeloid leukaemia

50. Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

Catalog

Books, media, physical & digital resources